A Phase I/II Study of Mitoxantrone Liposome Combined With Chidamide in Relapsed/Refractory Peripheral T-cell Lymphoma

NCT05527275 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Relapsed and Refractory Peripheral T-cell Lymphoma

Interventions

DRUG: Mitoxantrone liposome combine with Chidamide

Sponsor

Sun Yat-sen University